Cambrian Bioworks

Cambrian Bioworks is a biotechnology research company founded in 2020 that develops automated solutions for genomic testing and molecular diagnostics. The company designs and manufactures specialized hardware and software to streamline workflows such as DNA and RNA extraction and library preparation. By integrating bead-based systems with automation, their technology is engineered to be flexible, intuitive, and accessible to clinical laboratories. A core product, the Manta platform, is CE-marked under IVDR and holds CDSCO certification, reflecting the company’s commitment to meeting rigorous clinical quality and reliability standards in its diagnostic tools.

These solutions are designed to support precision medicine, oncology, infectious disease diagnostics, and genetic testing, ultimately aiming to democratize lab technology and assist scientists in providing fast, accurate results for patient care. Headquartered in Bangalore, India, with a presence in the United States, Cambrian Bioworks functions as a team of engineers, scientists, and chemists focused on building products that address the high-stakes needs of molecular diagnostic workflows. Through these efforts, they work to improve diagnostic efficiency and accessibility, enabling laboratories to maintain greater control over their testing processes and data.